Regulatory Success Starts Beyond a Compliant Dossier In the GCC, regulatory success is often perceived as a matter of documentation, a complete dossier, aligned formats, and technically sound data. While these elements remain essential, experienced regulatory...
In this exclusive interview, Mr. Görkem Aydin, Chief Marketing Officer at VISIOTT TPS, our Platinum Sponsor, shares practical insights into the complexities of pharmaceutical track-and-trace across the GCC. From navigating SFDA and MoHAP requirements to integrating...
In the rapidly evolving pharmaceutical landscape, ensuring patient safety remains a top priority for regulators and industry leaders alike. Pharmacovigilance, the science and activities relating to the detection, assessment, and prevention of adverse effects or any...
